Literature DB >> 8639834

Platelet-derived microparticles associate with fibrin during thrombosis.

P Siljander1, O Carpen, R Lassila.   

Abstract

Platelet-derived microparticles (MP) are reported to express both pro- and anticoagulant activities. Nevertheless, their functional significance has remained unresolved. The present study monitored the generation and fate of MP in an experimental model of thrombosis with costimulation of platelets by collagen and thrombin. When minimally anticoagulated (0.5 micromol/L PPACK) blood was perfused over immobilized fibrillar type I collagen in a flow chamber at a low shear rate (300 s(-1)), endogenous thrombin was generated, as evidenced by thrombin-antithrombin III complex. In contrast to full anticoagulation 150 micromol/L PPACK) and the absence of collagen, large platelet aggregates and fibrin ensued during perfusions over collagen in the presence of thrombin. In these thrombi, MP, defined as GPIIbIIIa- and P-selectin-positive vesicles (<1 micron), were found to align fibrin in immunofluorescence and scanning immunoelectron microscopy. Moreover, in sections of embolectomized thromboemboli from patients GPIIbIIIa- and P-selectin-positive material compatible with MP was detected in a fibrin strand-like pattern. In vitro binding studies showed that MP bound to fibrin and acted there as procoagulants. In summary, we show that MP generated during thrombus formation associate with local fibrin. This adhesive function fibrin could imply a sustained modulatory role for MP in evolving thrombi.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639834

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes.

Authors:  Majed A Refaai; Richard P Phipps; Sherry L Spinelli; Neil Blumberg
Journal:  Thromb Res       Date:  2010-11-19       Impact factor: 3.944

2.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles.

Authors:  Daniel L Sprague; Bennett D Elzey; Scott A Crist; Thomas J Waldschmidt; Robert J Jensen; Timothy L Ratliff
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

Review 3.  Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.

Authors:  Ximing Li; Hongliang Cong
Journal:  Tex Heart Inst J       Date:  2009

Review 4.  Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.

Authors:  J M Walenga; W P Jeske; H L Messmore
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

5.  Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation.

Authors:  Imke C A Munnix; Marijke J E Kuijpers; Jocelyn Auger; Christella M L G D Thomassen; Peter Panizzi; Marc A M van Zandvoort; Jan Rosing; Paul E Bock; Steve P Watson; Johan W M Heemskerk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-30       Impact factor: 8.311

6.  Activation status of platelet aggregates and platelet microparticles shed in sheared whole blood.

Authors:  N P Rhodes; A P Shortland; A Rattray; R A Black; D F Williams
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

7.  Platelet reactions to modified surfaces under dynamic conditions.

Authors:  N P Rhodes; A P Shortland; A Rattray; D F Williams
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

8.  Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression.

Authors:  Ruihua Ma; Tiantian Ji; Degao Chen; Wenqian Dong; Huafeng Zhang; Xiaonan Yin; Jingwei Ma; Xiaoyu Liang; Yi Zhang; Guanxin Shen; Xiaofeng Qin; Bo Huang
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

9.  Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets.

Authors:  Catherine Martel; Sylvie Cointe; Pascal Maurice; Saïd Matar; Marta Ghitescu; Pierre Théroux; Arnaud Bonnefoy
Journal:  PLoS One       Date:  2011-04-15       Impact factor: 3.240

10.  High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Authors:  Sara Tehrani; Aleksandra Antovic; Fariborz Mobarrez; Koteiba Mageed; Per-Eric Lins; Ulf Adamson; Håkan N Wallén; Gun Jörneskog
Journal:  Diabetes Care       Date:  2011-12-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.